Strongest evidence
Moderate evidence
Limited evidence
Insufficient evidence
No evidence
Use caution
Safety & contraindications
Psychosis, schizophrenia & bipolar disorder
THC can precipitate psychosis; adolescent use is associated with roughly 2.4× the risk of schizophrenia, and cannabis is linked to worse outcomes in bipolar disorder. Avoid with a personal or family history of psychosis or bipolar disorder.
Sources: Cannabis & psychosis (review)
Pregnancy & breastfeeding
Prenatal cannabis exposure is linked to attention, cognitive, and psychotic-like problems in offspring. Avoid during pregnancy and breastfeeding.
Drug interactions
CBD inhibits liver CYP450 enzymes and can raise levels of other drugs — including warfarin (bleeding risk) and clobazam. Review interactions with a pharmacist.
Cannabinoid Hyperemesis Syndrome
Chronic heavy use can cause cyclic severe vomiting and abdominal pain, often temporarily relieved by hot showers.
Sources: CHS (JAMA)
Cardiovascular & driving
THC acutely raises heart rate and blood pressure (caution with heart disease) and impairs psychomotor function — do not drive impaired.
Sources: NASEM 2017 conclusions
An evolving, patient-first resource
Cannabis research is young and moving fast. Areto is committed to growing this section responsibly — grounded in peer-reviewed evidence — so it can genuinely help medical patients make informed choices. We continually add new studies and welcome sources from clinicians and researchers at genetics@areto.tech.